BRACE Award Venture Competition

The BRACE Award Venture Competition Investment Committee is comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the Asian Fund for Cancer Research (AFCR). Its members will determine the winner between the event’s two finalists. The winner will receive the equivalent of HK$2,000,000 in investment funding from AFCR, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.

Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!

Raju Kucherlapati, Ph.D., Chair
Paul C. Cabot Professor of Genetics & Professor of Medicine, Harvard Medical School

Brian Leyland-Jones, MBBS, Ph.D.
Chief Medical Officer, AIM-HI Accelerator Fund

Will Liu, Ph.D.
Partner, Eight Roads Ventures

Alfred Slanetz, Ph.D.
President & CEO, Geneius Biotechnology, Inc.

Yajun Xu, Ph.D.
Managing Parrtner, Hongsen Capital